Prognostic role of preoperative skeletal muscle mass index in surgical lung cancer patients: a systematic review with meta-analysis.
Аннотация
BACKGROUND
The prognostic value of preoperative skeletal muscle mass index (SMI) in lung cancer patients who undergo the surgery remains unclear. This meta-analysis aimed to clarify prognostic value of preoperative SMI with long-term survival among operated lung cancer patients.
METHODS
PubMed, Cochrane Library, and Web of Science databases were searched up to March 21, 2026. Endpoints for survival included the overall survival (OS), disease-free survival (DFS) and cancer-specific survival (CSS). Subgroup analyses stratified by the neoadjuvant therapy and tumor type for OS were further performed.
RESULTS
Fourteen retrospective studies with 8,008 participants were included. After combining available data, it was identified that a lower SMI was associated with poorer OS [hazard ratio (HR) =1.35, 95% confidence interval (CI): 1.30-1.52, P<0.001] and DFS (HR =2.10, 95% CI: 1.06-4.15, P=0.03) and potentially poorer CSS (HR =1.64, 95% CI: 0.91-2.95, P=0.10). Subgroup analyses for the OS based on the neoadjuvant therapy (no: HR =1.90, P=0.003; yes: HR =2.50, P=0.03; mixed: HR =1.27, P=0.004) and tumor type (non-small cell lung cancer: HR =1.28, P<0.001; lung cancer: HR =2.03, P<0.001) manifested consistent results.
CONCLUSIONS
Lower preoperative SMI was associated with worse survival among surgical lung cancer patients and may have potential value in prognostic assessment.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.